HCA Healthcare Files 8-K on Financials and Operations
Ticker: HCA · Form: 8-K · Filed: Oct 24, 2025 · CIK: 860730
Sentiment: neutral
Topics: financial-reporting, operations, sec-filing
Related Tickers: HCA
TL;DR
HCA Healthcare dropped an 8-K on Oct 24th covering financials and other key updates.
AI Summary
HCA Healthcare, Inc. filed an 8-K on October 24, 2025, reporting on its results of operations and financial condition. The filing also included disclosures related to Regulation FD, other events, and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Nashville, Tennessee.
Why It Matters
This filing provides investors with crucial updates on HCA Healthcare's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual risks.
Key Players & Entities
- HCA Healthcare, Inc. (company) — Registrant
- October 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Nashville, Tennessee (location) — Principal executive office location
- 001-11239 (identifier) — Commission File Number
- 27-3865930 (identifier) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on HCA Healthcare, Inc.'s results of operations and financial condition, as well as to disclose other events and provide financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 24, 2025.
In which state is HCA Healthcare, Inc. incorporated?
HCA Healthcare, Inc. is incorporated in Delaware.
What is the address of HCA Healthcare, Inc.'s principal executive office?
The address of HCA Healthcare, Inc.'s principal executive office is One Park Plaza, Nashville, Tennessee, 37203.
What is the Commission File Number for HCA Healthcare, Inc.?
The Commission File Number for HCA Healthcare, Inc. is 001-11239.
Filing Stats: 522 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2025-10-24 07:16:56
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share HCA New York St
- $0.72 — d declared a quarterly cash dividend of $0.72 per share of the Company's common stock
Filing Documents
- hca-20251024.htm (8-K) — 46KB
- hca-ex99_1.htm (EX-99.1) — 1206KB
- img60930783_0.jpg (GRAPHIC) — 99KB
- 0001193125-25-249345.txt ( ) — 1536KB
- hca-20251024.xsd (EX-101.SCH) — 24KB
- hca-20251024_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 24, 2025, HCA Healthcare, Inc. (the "Company") issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1 .
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 24, 2025, the Company issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1 .
01. Other Events
Item 8.01. Other Events. On October 24, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company's common stock. The dividend will be paid on December 29, 2025 to stockholders of record at the close of business on December 15, 2025.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press Release, dated October 24, 2025 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. Date: October 24, 2025 By: /s/ Michael A. Marks Michael A. Marks Executive Vice President and Chief Financial Officer